FR2076787A5 - Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin - Google Patents

Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Info

Publication number
FR2076787A5
FR2076787A5 FR7002975A FR7002975A FR2076787A5 FR 2076787 A5 FR2076787 A5 FR 2076787A5 FR 7002975 A FR7002975 A FR 7002975A FR 7002975 A FR7002975 A FR 7002975A FR 2076787 A5 FR2076787 A5 FR 2076787A5
Authority
FR
France
Prior art keywords
viruses
albumin
contg
potassium phosphate
lyophilisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7002975A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR7002975A priority Critical patent/FR2076787A5/fr
Application granted granted Critical
Publication of FR2076787A5 publication Critical patent/FR2076787A5/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36251Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
FR7002975A 1970-01-28 1970-01-28 Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin Expired FR2076787A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7002975A FR2076787A5 (en) 1970-01-28 1970-01-28 Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7002975A FR2076787A5 (en) 1970-01-28 1970-01-28 Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Publications (1)

Publication Number Publication Date
FR2076787A5 true FR2076787A5 (en) 1971-10-15

Family

ID=9049721

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7002975A Expired FR2076787A5 (en) 1970-01-28 1970-01-28 Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Country Status (1)

Country Link
FR (1) FR2076787A5 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
FR2532548A1 (fr) * 1982-09-03 1984-03-09 Pasteur Institut Nouveau procede de production de vaccins presentant un titre eleve de virus et vaccins tres purifies, a titre eleve de virus, ainsi obtenus
EP0028563B1 (fr) * 1979-10-29 1984-04-04 Merck & Co. Inc. Stabilisant pour vaccins liquides et vaccin liquide contenant ledit stabilisant
US4555401A (en) * 1980-07-03 1985-11-26 The Green Cross Corporation Live mumps vaccine and method of stabilizing the same
WO1995010601A1 (fr) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Procedes de conservation de virus de recombinaison
WO2001005941A3 (fr) * 1999-07-16 2001-07-19 Health Lab Service Board Conservation de micro-organismes, de cellules et de tissus
EP0872249A4 (fr) * 1995-03-17 2001-10-24 Hisamitsu Pharmaceutical Co Preparation de transfert genique
RU2686108C2 (ru) * 2012-10-02 2019-04-24 Трансген Са Вирусосодержащий препарат и его применение

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124941C (fr) *
NL296078A (fr) *
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation
US3014843A (en) * 1955-02-07 1961-12-26 Armour & Co Method of producing non-virulent strains of attenuated and stabilized hog cholera virus
FR1299503A (fr) * 1960-01-18 1962-07-27 Anchor Serum Company Procédé d'atténuation de virus de la rhinotrachéite infectieuse des bovins
GB1000907A (en) * 1961-11-08 1965-08-11 Dow Chemical Co Attenuated live measles virus vaccine and method of production
DE1209245B (de) * 1961-11-08 1966-01-20 Dow Chemical Co Verfahren zur Herstellung von Masernimpfstoffen
GB1049386A (en) * 1962-08-16 1966-11-23 Parke Davis & Co Improvements in or relating to stabilized virus antigens
BE685270A (fr) * 1965-08-13 1967-02-09
BE700795A (fr) * 1965-07-29 1968-01-02
BE701496A (fr) * 1967-05-22 1968-01-18
US3366543A (en) * 1964-08-17 1968-01-30 American Home Prod Process of attenuating infectious bovine rhinotracheitis viruses
BE720444A (fr) * 1967-09-05 1969-03-05
GB1152626A (en) * 1967-07-07 1969-05-21 Merck & Co Inc Rubella Vaccine

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL296078A (fr) *
NL124941C (fr) *
US3014843A (en) * 1955-02-07 1961-12-26 Armour & Co Method of producing non-virulent strains of attenuated and stabilized hog cholera virus
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation
FR1299503A (fr) * 1960-01-18 1962-07-27 Anchor Serum Company Procédé d'atténuation de virus de la rhinotrachéite infectieuse des bovins
GB1000907A (en) * 1961-11-08 1965-08-11 Dow Chemical Co Attenuated live measles virus vaccine and method of production
DE1209245B (de) * 1961-11-08 1966-01-20 Dow Chemical Co Verfahren zur Herstellung von Masernimpfstoffen
GB1049386A (en) * 1962-08-16 1966-11-23 Parke Davis & Co Improvements in or relating to stabilized virus antigens
US3366543A (en) * 1964-08-17 1968-01-30 American Home Prod Process of attenuating infectious bovine rhinotracheitis viruses
BE700795A (fr) * 1965-07-29 1968-01-02
BE685270A (fr) * 1965-08-13 1967-02-09
BE701496A (fr) * 1967-05-22 1968-01-18
GB1152645A (en) * 1967-05-22 1969-05-21 Merck & Co Inc Rubella Vaccine
FR1583642A (fr) * 1967-05-22 1969-11-21
GB1152626A (en) * 1967-07-07 1969-05-21 Merck & Co Inc Rubella Vaccine
BE720444A (fr) * 1967-09-05 1969-03-05
NL6812467A (fr) * 1967-09-05 1969-03-07

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028563B1 (fr) * 1979-10-29 1984-04-04 Merck & Co. Inc. Stabilisant pour vaccins liquides et vaccin liquide contenant ledit stabilisant
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4555401A (en) * 1980-07-03 1985-11-26 The Green Cross Corporation Live mumps vaccine and method of stabilizing the same
US4500512A (en) * 1981-05-13 1985-02-19 Institut Pasteur Stabilizing agents for live viruses for preparing vaccines, and stabilized vaccines containing said stabilizing agents
EP0065905A1 (fr) * 1981-05-13 1982-12-01 Institut Pasteur Perfectionnements apportés aux agents de stabilisation de virus vivants pour la préparation de vaccins, et vaccins stabilisés contenant lesdits agents de stabilisation
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
FR2532548A1 (fr) * 1982-09-03 1984-03-09 Pasteur Institut Nouveau procede de production de vaccins presentant un titre eleve de virus et vaccins tres purifies, a titre eleve de virus, ainsi obtenus
WO1995010601A1 (fr) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Procedes de conservation de virus de recombinaison
US5792643A (en) * 1993-10-12 1998-08-11 Herrmann; Steven M. Methods for preserving recombinant retroviruses
EP0872249A4 (fr) * 1995-03-17 2001-10-24 Hisamitsu Pharmaceutical Co Preparation de transfert genique
WO2001005941A3 (fr) * 1999-07-16 2001-07-19 Health Lab Service Board Conservation de micro-organismes, de cellules et de tissus
RU2686108C2 (ru) * 2012-10-02 2019-04-24 Трансген Са Вирусосодержащий препарат и его применение

Similar Documents

Publication Publication Date Title
IT950452B (it) Sistema e disposizione per comanda re la frenatura e la marcia di og getti
NL167818C (nl) Stelsel voor de geheime overdracht van berichten.
FR2076787A5 (en) Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin
NL169982B (nl) Werkwijze voor de bereiding van gezuiverde alkalimetaalfosfaatoplossingen.
KR780000220B1 (en) Method of interconneting thermoplstic meterial
CH549422A (de) Schmiedepresse zur kaltverformung von werkstuecken.
GB1188714A (en) Method for the Continuous Preparation of an Aqueous Ammoniated Phosphate Composition
DK130192B (da) Fremgangsmåde til kontinuerlig varmebehandling af stavformige bygningsstål med lavt carbonindhold.
YU262271A (en) Process for an enzymatic cleaving of lactose from milk or derivatives thereof
IL38264A (en) Production of potassium dihydrogen phosphate
NL159067B (nl) Werkwijze voor de bereiding van mono- en/of diammoniumfosfaat.
IT973022B (it) Impianto di frenatura adattiva particolarmente per ruote di au toveicoli
IL38330A0 (en) Production of potassium dihydrogen phosphate/potassium nitrate mixtures
CA933072A (en) Method for controlling the nitriding tendency of aluminium-killed steel
FR2157683A1 (en) Phosphate fertiliser - contg dross,sulphur,and phosphogypsum
NL161419B (nl) Werkwijze voor de bereiding van fosforzuur.
DK125549B (da) Drivladnings-krudtlegeme samt fremgangsmåde til dets fremstilling.
SU144577A1 (ru) Способ получени кормового концентрата витамина B12
NL149063B (nl) Werkwijze voor de bereiding van gestabiliseerde, fosforzuuresters bevattende mengsels en gevormde preparaten die deze mengsels bevatten.
DK134479B (da) Fremgangsmåde til fremstilling af monocalcium-, dicalcium- eller monoammoniumphosphat.
CA626123A (en) Method of conditioning steel for nitriding
CA834640A (en) Manufacture of monoammonium phosphate
FI44506C (fi) Menetelmä rauta- ja teräspintojen fosfatoimiseksi
CA785205A (en) Process for the stabilization of dicalcium phosphate dihydrate
FR1372683A (fr) Système de suspension des roues motrices indépendantes, notamment de véhicules

Legal Events

Date Code Title Description
ST Notification of lapse